145 related articles for article (PubMed ID: 36621944)
1. The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
Weill C; Gallant A; Baker Erdman H; Abu Snineh M; Linetsky E; Bergman H; Israel Z; Arkadir D
Mov Disord; 2023 Mar; 38(3):484-489. PubMed ID: 36621944
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants.
Pal GD; Corcos DM; Metman LV; Israel Z; Bergman H; Arkadir D
Mov Disord; 2023 Dec; 38(12):2155-2162. PubMed ID: 37916476
[TBL] [Abstract][Full Text] [Related]
3. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
[TBL] [Abstract][Full Text] [Related]
4. Analysis of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with monogenic PRKN and LRRK2 forms of Parkinson's disease.
Prendes Fernández P; Blázquez Estrada M; Sol Álvarez J; Álvarez Martínez V; Suárez San Martín E; García Fernández C; Álvarez Carriles JC; Lozano Aragoneses B; Saiz Ayala A; Santamarta Liébana E; González Álvarez L
Parkinsonism Relat Disord; 2023 Feb; 107():105282. PubMed ID: 36657280
[TBL] [Abstract][Full Text] [Related]
5. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
[TBL] [Abstract][Full Text] [Related]
6. Christmas-Related Reduction in Beta Activity in Parkinson's Disease.
Feldmann LK; Lofredi R; Al-Fatly B; Busch JL; Mathiopoulou V; Roediger J; Krause P; Schneider GH; Faust K; Horn A; Kühn AA; Neumann WJ
Mov Disord; 2023 Apr; 38(4):692-697. PubMed ID: 36718788
[TBL] [Abstract][Full Text] [Related]
7. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus.
Rappel P; Grosberg S; Arkadir D; Linetsky E; Abu Snineh M; Bick AS; Tamir I; Valsky D; Marmor O; Abo Foul Y; Peled O; Gilad M; Daudi C; Ben-Naim S; Bergman H; Israel Z; Eitan R
Mov Disord; 2020 Feb; 35(2):337-343. PubMed ID: 31758821
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
[TBL] [Abstract][Full Text] [Related]
9. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson's Disease.
Trevarrow MP; Munoz MJ; Rivera YM; Arora R; Drane QH; Rosenow JM; Sani SB; Pal GD; Verhagen Metman L; Goelz LC; Corcos DM; David FJ
J Parkinsons Dis; 2023; 13(6):917-935. PubMed ID: 37522216
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical Modulation of STN β-Band Activity with Medication Compared to Deep Brain Stimulation.
Hill ME; Johnson LA; Wang J; Escobar Sanabria D; Patriat R; Cooper SE; Park MC; Harel N; Vitek JL; Aman JE
Mov Disord; 2024 Jan; 39(1):192-197. PubMed ID: 37888906
[TBL] [Abstract][Full Text] [Related]
13. Physical activity levels in people with Parkinson's disease treated by subthalamic nucleus deep brain stimulation.
Danoudis M; Iansek R
Disabil Rehabil; 2023 Sep; 45(18):2890-2895. PubMed ID: 36124542
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
[TBL] [Abstract][Full Text] [Related]
15. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
[TBL] [Abstract][Full Text] [Related]
16. Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease.
Udupa K; Bahl N; Ni Z; Gunraj C; Mazzella F; Moro E; Hodaie M; Lozano AM; Lang AE; Chen R
J Neurosci; 2016 Jan; 36(2):396-404. PubMed ID: 26758832
[TBL] [Abstract][Full Text] [Related]
17. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
[TBL] [Abstract][Full Text] [Related]
18. Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia.
Olson JW; Nakhmani A; Irwin ZT; Edwards LJ; Gonzalez CL; Wade MH; Black SD; Awad MZ; Kuhman DJ; Hurt CP; Guthrie BL; Walker HC
Mov Disord; 2022 Aug; 37(8):1683-1692. PubMed ID: 35702056
[TBL] [Abstract][Full Text] [Related]
19. The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life.
Tödt I; Al-Fatly B; Granert O; Kühn AA; Krack P; Rau J; Timmermann L; Schnitzler A; Paschen S; Helmers AK; Hartmann A; Bardinet E; Schuepbach M; Barbe MT; Dembek TA; Fraix V; Kübler D; Brefel-Courbon C; Gharabaghi A; Wojtecki L; Pinsker MO; Thobois S; Damier P; Witjas T; Houeto JL; Schade-Brittinger C; Vidailhet M; Horn A; Deuschl G
Mov Disord; 2022 Feb; 37(2):291-301. PubMed ID: 35112384
[TBL] [Abstract][Full Text] [Related]
20. Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.
Onofrj M; Di Iorio A; Carrarini C; Russo M; Franciotti R; Espay AJ; Boylan LS; Taylor JP; Di Giannantonio M; Martinotti G; Valente EM; Thomas A; Bonanni L; Delli Pizzi S; Dono F; Sensi S
Mov Disord; 2021 Dec; 36(12):2840-2852. PubMed ID: 34427338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
